Trial Profile
A Study to Compare the Healthcare Resource Utilization (HRU) among Deep Vein Thrombosis (DVT) Patients who Received Rivaroxaban or Low-Molecular-Weight Heparin (LMWH) and Warfarin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Low molecular weight heparins; Warfarin
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 25 Feb 2016 New trial record